Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.98% shed 1.15% to $162.97 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.95% rising 0.28% to 4,410.13 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.60% rising 0.29% to 34,364.50. This was the stock's 10th consecutive day of losses. Johnson & Johnson closed $16.95 below its 52-week high ($179.92), which the company achieved on August 20th.
Despite its losses, the stock outperformed some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -1.16% fell 4.44% to $376.50, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.94% fell 1.44% to $78.83, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.56% fell 2.37% to $51.54.true Trading volume (14.0 M) eclipsed its 50-day average volume of 7.6 M.